What are the clinical features or factors that suggest treatment should be switched or stopped for people with diabetic macular oedema? For a short explanation of why the committee made this ...
Data from phase 3 trials of the drug in diabetic macular oedema (DMO) provide some encouragement for Novartis on the safety issue, with Beovu (brolucizumab) found to be roughly equivalent to Bayer ...
In people experiencing a rapid, substantial reduction in HbA1c, what is the risk of short-term progression of diabetic retinopathy or diabetic macular oedema, and is there a risk of long-term visual ...
Diabetes is a number of diseases that involve problems with the hormone insulin. There is no cure for diabetes. The warning signs of diabetes can be so mild that you don't notice them. That's ...
Novartis has chalked up a couple of positive trials for Beovu in diabetic macular oedema, another leading cause of blindness, but expectations aren't high that will jump start the drug's sales ...
The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...
“OCU200 has the potential to change the treatment landscape for DME, diabetic retinopathy (DR), and wet age-related macular degenerati It is a good idea to keep an eye on five biotech ...
Diabetes Test Results: Types of Tests and How to Read Them If you or someone in your family has diabetes, you might be wondering if it is genetic. There are different types of diabetes. For each type, ...
Over time type 2 diabetes can affect all body parts, including the feet. When blood sugars are not controlled, moist areas in the feet are prone to infections. People with diabetes can experience ...
Protect your vision in 2025 with these 10 simple eye care habits, from screen breaks to a nutrient-rich diet, ensuring long-term eye health and clarity.